UCHealth Hematology/Oncology Colorado Springs, Colorado
Learning Objectives:
Apply mechanistic understanding of bispecific antibody therapies to treatment of patients with relapsed/refractory multiple myeloma (R/R MM)
Describe and compare efficacy and adverse events of different target-specific antibody therapies in patients with R/R MM to improve patient outcomes and minimize toxicities associated with treatment
Discuss advances in implementation of current and emerging antibody therapy strategies, protocols, and clinical pathways within a hospital and/or ambulatory care setting